Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
20 hedge funds and large institutions have $9.41M invested in Vaxart in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
1% less capital invested
Capital invested by funds: $9.55M → $9.41M (-$135K)
9% less funds holding
Funds holding: 22 → 20 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
112% less ownership
Funds ownership: 168.2% → 56.2% (-112%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$397K |
| 2 |
Renaissance Technologies
New York
|
+$134K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.58K |
| 4 |
PA
Parallel Advisors
San Francisco,
California
|
+$1.16K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$13 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$430K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$31K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14.8K |
| 4 |
VF
Virtu Financial
New York
|
-$10K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$1K |
VXRT Hedge Fund Activity: Q4 2019 in Review
20 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2019, worth a combined $9.41M — down 1.4% from $9.55M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VXRT and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Armistice Capital, adding an estimated $397K. The largest seller was Sabby Management, exiting entirely with an estimated $430K sold.
- 20 institutional investors held Vaxart (VXRT) as of Q4 2019, down from 22 in Q3 2019.
- Funds reported $9.41M of Vaxart stock for Q4 2019, down 1.4% quarter-over-quarter.
- 3 funds opened new Vaxart positions in Q4 2019 and 5 closed out, a net change of -2 holders.
- The largest Vaxart buyer in Q4 2019 was Armistice Capital, an estimated $397K added.
- The largest Vaxart seller in Q4 2019 was Sabby Management, an estimated $430K sold.
Based on aggregated 13F filings for Q4 2019.